Objectives : To evaluate the effects and sequelae of transccrvical resection of the endomctrium (TCRE) and thermachoice balloon ablation in the management of perimenopausal dysfunctional uterine bleeding. Design: Prospective study. Setting : Tanta and Cairo University Hospitals. Patients : The study included 70 women complaining of primenopausal dysfunctional uterine bleeding. Intervention: Women were randomized to cither treatment with the cndomelrial resection or thermal balloon ablation and followed up for 6 months. Outcome measures: Evaluation of treatment efficacy was done by a scoring system. Quantification of the quality of life aspects was done via a special questionnaire.
hysleroscopic ablation requires additional specialized training and surgical expertise. Moreover, serious complications may occur, including fluid overload, uterine perforation, infection, haemorrhage, thermal injuries, and even death. In the Mistlcstoc study, 10,686 women were treated with endomctrial ablation performed by 690 different surgeons and by different methods; the complication rate was 4.4%™'.
In the interests of overcoming many of these disadvantages and risks, a thermal uterine balloon therapy system was developed that has been evaluated in several clinical studies of endomctrial destruction (10) (11) (12) M an y clinical studies were done to elucidate the role of thermal balloon in the amelioration of dysfunctional uterine bleeding C 3 " 16 ).
The aim of this study was to evaluate the effects and sequelae of hysleroscopic endomctrial resection and thermachoicc balloon ablation in the management of pcrimcnopausal dysfunction uterine bleeding. were recruited and randomized into 2 groups according to the given method of treatment.
• Group I: Included 35 patients where transcervical resection of the endomctrium (TCRE) was performed.
• Group II: Included 35 patients where ablation of the cndometnum was performed by thcrmachoice balloon.
Inclusion criteria :
-Patients at the pcrimenopausal age (40-50 years).
-Dysfunctional uterine bleeding with no organic pelvic pathology.
-Failure of medical treatment for at least 6 months.
-Failure of > one dilatation and curettage operation.
-Uterine size < 12 weeks size and the uterine cavity < 12 cm measured from fu'ndus to external cervical opening.
-All patients completed their family and wish to retain their uterus.
Exclusion criteria :
-Patients desiring amenorrhea as an end resutl of treatment.
-Uterine size > 12 weeks size and the uterine cavity > 12 cm.
-Congenital or acquired uterine malformations that distort the uterine cavity.
-Cases with endometrial polypi or fibroid uterus.
-Malignancy or alypia of endometrium as proved by recent hislopathology of curettage specimens.
-Cases of adenomatous hypcrplasia, despite they were not a contraindication, they were not included.
-Cases of coagulopathy known by history or investigations and Cases with FSH > 30 mlU/ml.
-Incidental adnexal abnormality, uninvesligated poslcoital bleeding and untreated abnormal cervical cytology.
-Severe dysmenorrhoea, severe premenstrual pain and chronic pelvic pain.
-Fixed relroverted uterus or the presenc eof pelvic tenderness.
-The presence of uterine scars (previous Cesarean section, myomectomy etc.).
-Medical contraindications to either treatment or history of previous endometrial ablation or resection,
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Women were randomized to either treatment with the endometrial resection or thermal balloon ablation and followed up for 3, 6 and 12 months. All patients in both groups were subjected to:
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• History taking, clinical and bimanual examination.
• • Ultrasonographic imaging to exclude large uterine or adnexal masses that may be missed by transvaginal examination.
• Diagnostic hystcroscopic examination and recent endometrial sampling was previously done in all patients in both groups.
• Operative procedure:
-Group I: Hysteroscopic transccrvical resection of the endometrium.
-Group II: Therma Choice Balloon therapy system ablation.
• Evaluation of treatment efficacy was done by Magos method 0 8) .
• To quantify the quality of life aspects we used the questionnaire developed and validated by Ruta et al (19) • Patient satisfaction was also assessed using a 10-cm VAS labeled as follows: not satisfied (0 3.5 cm); satisfied (4 7.5 cm); and very satisfied (8 10 cm).
The VAS score was obtained by measuring the distance marked on the VAS but rounded to the nearest 0.5 cm. The use of a categorical outcome rather than the raw numerical data from the visual analogue scores was used in the analysis as we consider it easier to interpret in terms of the clinical conditions, whereas the numbers may be difficult to translate easily to a clinical outcome. Although not validated, the clinical outcomes are directly related to the underlying score. VAS assessments were done prc-opcrativcly and assessed at the follow up visits.
RESULTS
The age of both groups, in group I ranged from Histopathological study of the endometrium revealed that endometrial hypcrplasia was the commonest endometrial pattern in both groups, constituting 57% in group I and 60% in group II.
There was no statistically significant difference in the histopathology of both groups. 
